Oxford Nanopore Technologies plc (OTCMKTS:ONTTF – Get Free Report) shares shot up 0.7% during trading on Wednesday . The company traded as high as $1.62 and last traded at $1.54. 80,101 shares were traded during trading, an increase of 344% from the average session volume of 18,059 shares. The stock had previously closed at $1.53.
Wall Street Analysts Forecast Growth
Separately, Royal Bank Of Canada reissued an “outperform” rating on shares of Oxford Nanopore Technologies in a research note on Wednesday, January 21st. Two research analysts have rated the stock with a Buy rating, According to MarketBeat.com, Oxford Nanopore Technologies presently has an average rating of “Buy”.
Check Out Our Latest Stock Analysis on Oxford Nanopore Technologies
Oxford Nanopore Technologies Stock Performance
Oxford Nanopore Technologies Company Profile
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company operates in Life Science Research Tools and Covid Testing segments. It offers MinION, a portable device for DNA and RNA; GridION, a flexible and self-contained benchtop nanopore sequencer to run and analyse up to five MinION or Flongle flow cells; MinION Mk 1C, a nano pore-based sequencer with analysis software and connectivity for self-contained and portable sequencing; Flongle, an adapter for MinION or GridION that enables DNA sequencing or cDNA sequencing on smaller and single-use flow cells; and PromethION 2 Solo, a sequencer for two PromethION flow cells.
Featured Stories
Receive News & Ratings for Oxford Nanopore Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
